Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrointestinal behavior of tenofovir DF in healthy volunteers
2011-005863-25Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) and hepatitis B (HBV) (2 arms), sponsored by KU Leuven. Primary endpoints: Gastrointestinal behavior of tenofovir disoproxil fumarate and Absorption of tenofovir disoproxil fumarate. Started Jan 2012; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2011-005863-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005863-25.